CTXR is BACK as our Imminent FDA Decision Nasdaq Play! Could this Past 52% Winner see another 280% Gains?

With 2 MAJOR Phase III products in the pipeline, CTXR is a past winner ready for the next leg and back on IMMINENT Alert!